Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2029-03-01 | Urovant Sciences Ltd. | UROV | Robinson James A. Jr. PEO;CEO/Urovant Sciences, Inc. | 929,117 | $0 | 0 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2028-05-20 | Urovant Sciences Ltd. | UROV | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. | 389,198 | $0 | 0 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2028-06-09 | Urovant Sciences Ltd. | UROV | Legault Pierre Director | 111,480 | $0 | 0 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2029-11-05 | Urovant Sciences Ltd. | UROV | BANSAL AJAY See Remarks | 280,098 | $0 | 0 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2030-06-01 | Urovant Sciences Ltd. | UROV | Hindman James M. Director | 85,000 | $0 | 0 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2028-05-29 | Urovant Sciences Ltd. | UROV | Kurstjens Sef Director | 111,480 | $0 | 0 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2030-06-02 | Urovant Sciences Ltd. | UROV | Johnston Walt See Remarks | 178,336 | $0 | 0 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2028-05-20 | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 241,397 | $0 | 0 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2027-11-19 | Urovant Sciences Ltd. | UROV | OCAMPO CHRISTINE PAO; CAO/Urovant Sciences,Inc. | 286,031 | $0 | 0 (Direct) | View |
| 2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2028-11-21 | Urovant Sciences Ltd. | UROV | POTTER MYRTLE S Director | 111,480 | $0 | 0 (Direct) | View |
| 2021-01-10 Tax Withholding | 2021-01-12 7:02 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Robinson James A. Jr. PEO; CEO/Urovant Sciences, Inc | 4,095 | $16.11 | 8,385 (Direct) | View |
| 2021-01-07 Tax Withholding | 2021-01-08 6:30 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. | 5,810 | $16.09 | 141,348 (Direct) | View |
| 2021-01-07 Tax Withholding | 2021-01-08 6:29 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 4,761 | $16.09 | 124,447 (Direct) | View |
| 2020-07-21 Option Award | 2020-07-23 4:35 pm | N/A 2030-07-21 | Urovant Sciences Ltd. | UROV | Hindman James M. Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-07-21 Option Award | 2020-07-23 4:33 pm | N/A 2030-07-21 | Urovant Sciences Ltd. | UROV | Legault Pierre Director | 24,000 | $0 | 36,480 (Direct) | View |
| 2020-07-21 Option Award | 2020-07-23 4:31 pm | N/A 2030-07-21 | Urovant Sciences Ltd. | UROV | POTTER MYRTLE S Director | 24,000 | $0 | 36,480 (Direct) | View |
| 2020-07-21 Option Award | 2020-07-23 4:28 pm | N/A 2030-07-21 | Urovant Sciences Ltd. | UROV | Kurstjens Sef Director | 24,000 | $0 | 36,480 (Direct) | View |
| 2020-06-02 Option Award | 2020-06-03 6:50 pm | N/A 2030-06-02 | Urovant Sciences Ltd. | UROV | Johnston Walt SVP, Commercial, USI | 177,844 | $0 | 177,844 (Direct) | View |
Ownership | 2020-06-03 6:45 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Johnston Walt SVP, Commercial, USI | 0 | $0 | 0 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-01 6:05 pm | N/A 2030-06-01 | Urovant Sciences Ltd. | UROV | Hindman James M. Director | 61,000 | $0 | 61,000 (Direct) | View |
Ownership | 2020-06-01 5:47 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Hindman James M. Director | 0 | $0 | 0 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-04 4:57 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. | 83,149 | $0 | 145,277 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-04 4:55 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 77,606 | $0 | 127,606 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-04 4:53 pm | N/A N/A | Urovant Sciences Ltd. | UROV | OCAMPO CHRISTINE PAO;CAO/Urovant Sciences, Inc | 44,346 | $0 | 77,179 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-04 4:51 pm | N/A N/A | Urovant Sciences Ltd. | UROV | BANSAL AJAY PFO;CFO/Urovant Sciences, Inc. | 63,659 | $0 | 138,659 (Direct) | View |
| 2020-03-23 Option Award | 2020-03-25 5:00 pm | N/A 2030-03-22 | Urovant Sciences Ltd. | UROV | Robinson James A. Jr. PEO;CEO/Urovant Sciences, Inc. | 845,732 | $0 | 845,732 (Direct) | View |